Mid-Term Results of Popliteal-Pedal Inframalleolar Vein Bypasses in Chronic Limb-Threatening Ischemia Patients After Previous Failed Tibial Endovascular Recanalization.

IF 16.4 1区 化学 Q1 CHEMISTRY, MULTIDISCIPLINARY
Nicola Troisi, Francesco Stilo, Daniele Adami, Giovanni De Caridi, Nunzio Montelione, Giulia Bertagna, Chiara Barillà, Raffaella Berchiolli, Francesco Spinelli, Filippo Benedetto
{"title":"Mid-Term Results of Popliteal-Pedal Inframalleolar Vein Bypasses in Chronic Limb-Threatening Ischemia Patients After Previous Failed Tibial Endovascular Recanalization.","authors":"Nicola Troisi, Francesco Stilo, Daniele Adami, Giovanni De Caridi, Nunzio Montelione, Giulia Bertagna, Chiara Barillà, Raffaella Berchiolli, Francesco Spinelli, Filippo Benedetto","doi":"10.1016/j.avsg.2024.10.006","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Inframalleolar bypass still preserves its role in the modern endovascular era. Aim of this study was to evaluate the mid-term outcomes of \"short\" inframalleolar vein bypasses in patients with chronic limb-threatening ischemia (CLTI) after the previously failed tibial endovascular recanalization.</p><p><strong>Methods: </strong>Between January 2015 and December 2021,107 CLTI patients in 3 Italian Departments of Vascular Surgery underwent \"short\" inframalleolar vein bypass after failed tibial endovascular recanalization. Early (30-day) and 3-year outcomes were evaluated in terms of survival, primary patency, primary assisted patency, secondary patency, and amputation-free survival. Univariate analysis of the perioperative factors affecting outcomes were performed by the means of log-rank test. The associations of procedure variables were sought based on a multivariate Cox regression analysis.</p><p><strong>Results: </strong>Distal anastomosis (inframalleolar) was mostly performed on dorsal pedis (64, 59.8%). At 30 days, bypass occlusion was recorded in 5 cases (4.6%). The mean follow-up period was 20.5 ± 17.9 months. The estimated 3-year overall survival was 66.7%. Three-year estimates of primary patency, primary assisted patency, secondary patency, and amputation-free survival were 68.5%, 70.1%, 70.2%, and 76.7%, respectively. Multivariate analysis showed a negative association of insulin treatment with primary patency (HR 4.3, P = 0.04), primary assisted patency (HR 5.1, P = 0.02), and secondary patency (HR 5.1, P = 0.02). The negative association of long-term corticosteroid use was also found with primary patency (HR 7.8, P = 0.005), primary assisted patency (HR 8.7, P = 0.003), secondary patency (HR 8.7, P = 0.003), and amputation-free survival (HR 3.9, P = 0.05).</p><p><strong>Conclusions: </strong>Short\" vein bypasses to the foot arteries in CLTI patients yielded good mid-term overall patency and limb salvage rates after a failed tibial endovascular recanalization. Insulin-dependent diabetes mellitus and long-term corticosteroid use seemed to affect the outcomes.</p>","PeriodicalId":1,"journal":{"name":"Accounts of Chemical Research","volume":null,"pages":null},"PeriodicalIF":16.4000,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Accounts of Chemical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.avsg.2024.10.006","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Inframalleolar bypass still preserves its role in the modern endovascular era. Aim of this study was to evaluate the mid-term outcomes of "short" inframalleolar vein bypasses in patients with chronic limb-threatening ischemia (CLTI) after the previously failed tibial endovascular recanalization.

Methods: Between January 2015 and December 2021,107 CLTI patients in 3 Italian Departments of Vascular Surgery underwent "short" inframalleolar vein bypass after failed tibial endovascular recanalization. Early (30-day) and 3-year outcomes were evaluated in terms of survival, primary patency, primary assisted patency, secondary patency, and amputation-free survival. Univariate analysis of the perioperative factors affecting outcomes were performed by the means of log-rank test. The associations of procedure variables were sought based on a multivariate Cox regression analysis.

Results: Distal anastomosis (inframalleolar) was mostly performed on dorsal pedis (64, 59.8%). At 30 days, bypass occlusion was recorded in 5 cases (4.6%). The mean follow-up period was 20.5 ± 17.9 months. The estimated 3-year overall survival was 66.7%. Three-year estimates of primary patency, primary assisted patency, secondary patency, and amputation-free survival were 68.5%, 70.1%, 70.2%, and 76.7%, respectively. Multivariate analysis showed a negative association of insulin treatment with primary patency (HR 4.3, P = 0.04), primary assisted patency (HR 5.1, P = 0.02), and secondary patency (HR 5.1, P = 0.02). The negative association of long-term corticosteroid use was also found with primary patency (HR 7.8, P = 0.005), primary assisted patency (HR 8.7, P = 0.003), secondary patency (HR 8.7, P = 0.003), and amputation-free survival (HR 3.9, P = 0.05).

Conclusions: Short" vein bypasses to the foot arteries in CLTI patients yielded good mid-term overall patency and limb salvage rates after a failed tibial endovascular recanalization. Insulin-dependent diabetes mellitus and long-term corticosteroid use seemed to affect the outcomes.

曾接受胫骨血管内再通术失败的 CLTI 患者接受腘腓肠肌下静脉搭桥术的中期效果。
目的:在现代血管内手术时代,髂内静脉搭桥术仍然发挥着重要作用。本研究旨在评估胫骨血管内再通失败后的慢性肢体缺血(CLTI)患者接受 "短 "髂内静脉搭桥术的中期疗效:2015年1月至2021年12月期间,意大利3个血管外科部门的107名CLTI患者在胫骨血管内再通术失败后接受了 "短 "踝下静脉搭桥术。对患者早期(30 天)和 3 年的生存率、主要通畅率、主要辅助通畅率、次要通畅率和无截肢生存率进行了评估。通过对数秩检验对影响疗效的围手术期因素进行了单变量分析。根据多变量 Cox 回归分析寻找手术变量之间的关联:远端吻合术(脐下)大多在足背进行(64例,59.8%)。30天后,5例患者(4.6%)出现旁路闭塞。平均随访时间为 20.5 ± 17.9 个月。估计三年总存活率为 66.7%。主要通畅率、主要辅助通畅率、次要通畅率和无截肢存活率的三年估计值分别为 68.5%、70.1%、70.2% 和 76.7%。多变量分析显示,胰岛素治疗与一次通畅率(HR 4.3,P = .04)、一次辅助通畅率(HR 5.1,P = .02)和二次通畅率(HR 5.1,P = .02)呈负相关。长期使用皮质类固醇还与一次通畅率(HR 7.8,p = .005)、一次辅助通畅率(HR 8.7,p = .003)、二次通畅率(HR 8.7,p = .003)和无截肢生存率(HR 3.9,p = .05)呈负相关:结论:CLTI 患者足部动脉的 "短 "静脉搭桥术可获得良好的中期总体通畅率,以及胫骨血管内再通失败后的肢体挽救率。胰岛素依赖型糖尿病和长期使用皮质类固醇似乎会影响治疗效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Accounts of Chemical Research
Accounts of Chemical Research 化学-化学综合
CiteScore
31.40
自引率
1.10%
发文量
312
审稿时长
2 months
期刊介绍: Accounts of Chemical Research presents short, concise and critical articles offering easy-to-read overviews of basic research and applications in all areas of chemistry and biochemistry. These short reviews focus on research from the author’s own laboratory and are designed to teach the reader about a research project. In addition, Accounts of Chemical Research publishes commentaries that give an informed opinion on a current research problem. Special Issues online are devoted to a single topic of unusual activity and significance. Accounts of Chemical Research replaces the traditional article abstract with an article "Conspectus." These entries synopsize the research affording the reader a closer look at the content and significance of an article. Through this provision of a more detailed description of the article contents, the Conspectus enhances the article's discoverability by search engines and the exposure for the research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信